Capitalizing glycomic changes for improved biomarker-based cancer diagnostics

Cancer serum biomarkers are valuable or even indispensable for cancer diagnostics and/or monitoring and, currently, many cancer serum markers are routinely used in the clinic. Most of those markers are glycoproteins, carrying cancer-specific glycan structures that can provide extra-information for c...

Descripción completa

Detalles Bibliográficos
Autor principal: Silva, Maria Luísa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344901/
https://www.ncbi.nlm.nih.gov/pubmed/37455827
http://dx.doi.org/10.37349/etat.2023.00140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344901/
https://www.ncbi.nlm.nih.gov/pubmed/37455827
http://dx.doi.org/10.37349/etat.2023.00140

Ejemplares similares